originally posted on LinkedIn.
—by Amina Larbi,
Subscribe in seconds and receive MPP's news feed updates in your inbox, on your phone or even read them from your own news page here on follow.it.
You can select the updates using tags or topics and you can add as many websites to your feed as you like.
And the service is entirely free!
Follow MPP: MPP Home - The Medicines Patent Pool
Is this your feed? Claim it!
originally posted on LinkedIn.
—by Amina Larbi,
To further strengthen regional supply resilience and diversify manufacturing capacity, MPP has launched a targeted regional Expression of Interest (EOI), open exclusively to eligible manufacturers from the Latin American and Caribbean region, to recruit one additional licensee for baloxavir marboxil, an innovative antiviral treatment for influenza recommended by the World Hea...
Carlo Giaquinto, Professor of Paediatrics, President of the Penta Foundation and coordinator of the Penta ID Network
RSV causes severe illness and pneumonia in young children, particularly in low- and middle-income countries. MPP is exploring how voluntary licensing could support earlier, more affordable access to new RSV medi...
The Medicines Patent Pool (MPP), Belgian biotechnology company SwiftPharma and South Africa’s Council for Scientific and Industrial Research (CSIR) signed a binding agreement to transfer innovative plant-based ...
The post Request for Proposals: Hosting, Maintenance, Support and Development of the MedsPaL Platform appeared first on